Circulating SOD2 Is a Candidate Response Biomarker for Neoadjuvant Therapy in Breast Cancer.
Juliachs M, Pujals M, Bellio C, Meo-Evoli N, Duran JM, Zamora E, Parés M, Suñol A, Méndez O, Sánchez-Pla A, Canals F, Saura C, Villanueva J.
Juliachs M, et al. Among authors: duran jm.
Cancers (Basel). 2022 Aug 10;14(16):3858. doi: 10.3390/cancers14163858.
Cancers (Basel). 2022.
PMID: 36010852
Free PMC article.